Stock 3353 MEDICAL IKKOU GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medical Ikkou Group Co.,Ltd.

Equities

3353

JP3921040006

Drug Retailers

Market Closed - Japan Exchange
Other stock markets
 01:45:41 01/05/2024 BST 		5-day change 1st Jan Change
2,553 JPY -0.04% Intraday chart for Medical Ikkou Group Co.,Ltd. +2.32% +23.75%
2023 Medical Ikkou Group Co.,Ltd. agreed to acquire Okinawa Amel Co., Ltd. from Seibu Sawai Yakuhin K.K. CI
2023 Medical Ikkou Group Co.,Ltd. entered into basic agreement to acquire 50% stake in Hakuai Nakai Ethical Pharmacy Co., Ltd. from Kanichi Eguchi. CI

Valuation

Fiscal Period: February 2018 2019 2020 2021 2022 2023
Capitalization 1 22,265 17,270 16,488 11,307 9,578 9,727
Enterprise Value (EV) 1 26,981 23,068 20,970 16,151 12,897 12,399
P/E ratio 18 x 24.4 x 20.6 x 13.6 x 11.2 x 12.8 x
Yield 0.69% 0.88% 0.92% 2.66% 1.57% 1.54%
Capitalization / Revenue 0.72 x 0.55 x 0.51 x 0.36 x 0.29 x 0.29 x
EV / Revenue 0.87 x 0.74 x 0.65 x 0.51 x 0.38 x 0.37 x
EV / EBITDA 12.3 x 12.2 x 10.3 x 8.66 x 6.01 x 6.98 x
EV / FCF 28.3 x -34.8 x 14.9 x 15.6 x 13.8 x 16.7 x
FCF Yield 3.54% -2.87% 6.72% 6.43% 7.27% 5.99%
Price to Book 2.39 x 1.81 x 1.62 x 1.08 x 0.84 x 0.81 x
Nbr of stocks (in thousands) 3,832 3,812 3,812 3,757 3,756 3,757
Reference price 2 5,810 4,530 4,325 3,010 2,550 2,589
Announcement Date 25/05/18 23/05/19 28/05/20 27/05/21 26/05/22 25/05/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2018 2019 2020 2021 2022 2023
Net sales 1 30,914 31,222 32,042 31,603 33,595 33,897
EBITDA 1 2,192 1,892 2,030 1,865 2,145 1,776
EBIT 1 1,406 1,044 1,205 1,030 1,275 935
Operating Margin 4.55% 3.34% 3.76% 3.26% 3.8% 2.76%
Earnings before Tax (EBT) 1 1,939 1,167 1,271 1,443 1,476 1,312
Net income 1 1,238 711 801 836 852 759
Net margin 4% 2.28% 2.5% 2.65% 2.54% 2.24%
EPS 2 323.1 185.8 210.1 221.6 226.8 202.0
Free Cash Flow 1 955 -662.6 1,409 1,039 937.6 743.1
FCF margin 3.09% -2.12% 4.4% 3.29% 2.79% 2.19%
FCF Conversion (EBITDA) 43.57% - 69.4% 55.69% 43.71% 41.84%
FCF Conversion (Net income) 77.14% - 175.89% 124.24% 110.05% 97.91%
Dividend per Share 2 40.00 40.00 40.00 80.00 40.00 40.00
Announcement Date 25/05/18 23/05/19 28/05/20 27/05/21 26/05/22 25/05/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: February 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 16,063 15,522 16,812 8,399 8,563 16,978 8,449 8,721 17,450 11,319
EBITDA - - - - - - - - - -
EBIT 1 623 395 648 360 239 465 240 294 603 475
Operating Margin 3.88% 2.54% 3.85% 4.29% 2.79% 2.74% 2.84% 3.37% 3.46% 4.2%
Earnings before Tax (EBT) 1 643 708 784 396 333 624 373 374 775 499
Net income 1 397 434 445 225 208 374 223 211 444 368
Net margin 2.47% 2.8% 2.65% 2.68% 2.43% 2.2% 2.64% 2.42% 2.54% 3.25%
EPS 2 104.3 114.8 118.6 59.73 55.39 99.65 59.35 56.42 118.3 97.94
Dividend per Share 20.00 20.00 20.00 - - 20.00 - - 20.00 -
Announcement Date 30/09/19 30/09/20 30/09/21 11/01/22 04/07/22 03/10/22 10/01/23 03/07/23 02/10/23 10/01/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: February 2018 2019 2020 2021 2022 2023
Net Debt 1 4,716 5,798 4,482 4,844 3,319 2,672
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.151 x 3.064 x 2.208 x 2.597 x 1.547 x 1.505 x
Free Cash Flow 1 955 -663 1,409 1,039 938 743
ROE (net income / shareholders' equity) 14.2% 7.54% 8.12% 8.09% 7.75% 6.29%
ROA (Net income/ Total Assets) 3.47% 2.51% 2.87% 2.35% 2.76% 2.06%
Assets 1 35,666 28,297 27,870 35,550 30,819 36,757
Book Value Per Share 2 2,427 2,505 2,668 2,791 3,031 3,207
Cash Flow per Share 2 1,476 1,392 1,494 1,864 2,128 1,715
Capex 1 421 1,084 451 470 322 311
Capex / Sales 1.36% 3.47% 1.41% 1.49% 0.96% 0.92%
Announcement Date 25/05/18 23/05/19 28/05/20 27/05/21 26/05/22 25/05/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

1st Jan change Capi.
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+23.75% 62.75M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-10.75% 8.88B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+39.05% 1.43B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
+8.27% 438M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
-2.22% 268M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+10.56% 226M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-8.26% 86.33M
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-46.43% 82.6M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. 3353 Stock
  4. Financials Medical Ikkou Group Co.,Ltd.